{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:44:24Z","timestamp":1790127864775,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jep.2019.01.032","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T16:24:07Z","timestamp":1548865447000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum)"],"prefix":"10.1016","volume":"235","author":[{"given":"Greg E.","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2019.01.032_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12906-016-1046-8","article-title":"Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro","volume":"16","author":"Abu","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jep.2019.01.032_bib2","doi-asserted-by":"crossref","first-page":"e105244","DOI":"10.1371\/journal.pone.0105244","article-title":"Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro","volume":"9","author":"Abu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jep.2019.01.032_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1570-0232(04)00644-0","article-title":"Analysis of kavalactones from Piper methysticum (kava-kava)","volume":"812","author":"Bilia","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jep.2019.01.032_bib4","first-page":"1065","article-title":"Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999\u20132002","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jep.2019.01.032_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-017-1967-0","article-title":"Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice","author":"Chang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jep.2019.01.032_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1444-0903.2003.00405.x","article-title":"Health effects of kava use in an eastern Arnhem Land Aboriginal community","volume":"33","author":"Clough","year":"2003","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jep.2019.01.032_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbrc.2004.07.093","article-title":"Composition and biological activity of traditional and commercial kava extracts","volume":"322","author":"C\u00f4t\u00e9","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2019.01.032_bib8","first-page":"1293","article-title":"Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem. Toxicol","volume":"45","author":"DiSilvestro","year":"2007","journal-title":"Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"10.1016\/j.jep.2019.01.032_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phymed.2016.11.002","article-title":"Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro","volume":"24","author":"Einbond","year":"2017","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.jep.2019.01.032_bib10","unstructured":"Fratini Vergano Law Firm, 2015. Scientific and Legal assistance for the Development of a Quality and Safety Standard for Kava Production and Trade in the Pacific Region."},{"key":"10.1016\/j.jep.2019.01.032_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1078\/0944-7113-00369","article-title":"Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial","volume":"10","author":"Gastpar","year":"2003","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.jep.2019.01.032_bib12","first-page":"12","article-title":"Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage","author":"Hsieh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2019.01.032_bib13","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1021\/jf051853j","article-title":"In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)","volume":"54","author":"Jhoo","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jep.2019.01.032_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-12-55","article-title":"Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2\/M cell cycle arrest and apoptosis","volume":"12","author":"Ji","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jep.2019.01.032_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1055\/s-0035-1558295","article-title":"German Kava ban lifted by court: the alleged hepatotoxicity of Kava (Piper methysticum) as a case of Ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics","volume":"81","author":"Kuchta","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2019.01.032_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.foodchem.2013.11.120","article-title":"Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC)","volume":"151","author":"Lebot","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.jep.2019.01.032_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-0327(02)00238-0","article-title":"Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial","volume":"78","author":"Lehrl","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jep.2019.01.032_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/toxsci\/kfr235","article-title":"Methysticin and 7,8-Dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1","volume":"124","author":"Li","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jep.2019.01.032_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfm035","article-title":"Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats","volume":"97","author":"Lim","year":"2007","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.jep.2019.01.032_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.phymed.2007.11.003","article-title":"Hepatocellular toxicity of kava leaf and root extracts","volume":"15","author":"L\u00fcde","year":"2008","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.jep.2019.01.032_bib21","doi-asserted-by":"crossref","first-page":"e111572","DOI":"10.1371\/journal.pone.0111572","article-title":"Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster)","volume":"9","author":"Martin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jep.2019.01.032_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/dmd.30.11.1153","article-title":"Inhibition of human cytochrome P450 activities by kava extract and kavalactones","volume":"30","author":"Mathews","year":"2002","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.jep.2019.01.032_bib23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1124\/dmd.105.004317","article-title":"Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro","volume":"33","author":"Mathews","year":"2005","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.jep.2019.01.032_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jchromb.2005.08.003","article-title":"HPLC analysis of flavokavins and kavapyrones from Piper methysticum Forst","volume":"826","author":"Meissner","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jep.2019.01.032_bib25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/tx5003194","article-title":"Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL\/6 mice","volume":"27","author":"Narayanapillai","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jep.2019.01.032_bib26","first-page":"1","article-title":"Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344\/N rats and B6C3F1 mice (Gavage Studies)","author":"National Toxicology Program","year":"2012","journal-title":"Natl. Toxicol. Program Tech. Rep. Ser."},{"key":"10.1016\/j.jep.2019.01.032_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfh067","article-title":"In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones","volume":"79","author":"Nerurkar","year":"2004","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.jep.2019.01.032_bib28","unstructured":"Nutrition, C.forF.S.andA., n.d. Safety Alerts & Advisories - Consumer Advisory: Kava-Containing Dietary Supplements May be Associated With Severe Liver Injury [WWW Document]. URL \u3008http:\/\/wayback.archive-it.org\/7993\/20171114232640\/https:\/\/www.fda.gov\/Food\/RecallsOutbreaksEmergencies\/SafetyAlertsAdvisories\/ucm085482.htm\u3009 (accessed 10 March 2018)."},{"key":"10.1016\/j.jep.2019.01.032_bib29","doi-asserted-by":"crossref","DOI":"10.1089\/acm.2018.0001","article-title":"Kava for generalized anxiety disorder: a review of current evidence","author":"Ooi","year":"2018","journal-title":"J. Altern. Complement. Med. N. Y. N"},{"key":"10.1016\/j.jep.2019.01.032_bib30","series-title":"Assessment of the risk of hepatotoxicity with kava products","author":"Organisation mondiale de la sant\u00e9","year":"2007"},{"key":"10.1016\/j.jep.2019.01.032_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jor.22050","article-title":"Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines","volume":"30","author":"Sakai","year":"2012","journal-title":"J. Orthop. Res. Off. Publ. Orthop. Res. Soc."},{"key":"10.1016\/j.jep.2019.01.032_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-009-1549-9","article-title":"The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum","volume":"205","author":"Sarris","year":"2009","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.jep.2019.01.032_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00048674.2010.522554","article-title":"Kava: a comprehensive review of efficacy, safety, and psychopharmacology","volume":"45","author":"Sarris","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jep.2019.01.032_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/hup.2216","article-title":"The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study","volume":"27","author":"Sarris","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jep.2019.01.032_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/JCP.0b013e318291be67","article-title":"Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study","volume":"33","author":"Sarris","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jep.2019.01.032_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/10755530360623284","article-title":"Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory","volume":"9","author":"Schmidt","year":"2003","journal-title":"J. Altern. Complement. Med. N. Y. N."},{"key":"10.1016\/j.jep.2019.01.032_bib37","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/ptr.4652","article-title":"Pacific island \u2019Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells","volume":"26","author":"Shimoda","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jep.2019.01.032_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0305-1978(01)00093-X","article-title":"Identification of factors determining kavalactone content and chemotype in Kava (Piper methysticum Forst. f.)","volume":"30","author":"Sim\u00e9oni","year":"2002","journal-title":"Biochem. Syst. Ecol."},{"key":"10.1016\/j.jep.2019.01.032_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-8741(92)90003-A","article-title":"Kava: an overview","volume":"37","author":"Singh","year":"1992","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2019.01.032_bib40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2003-40658","article-title":"Aqueous kava extracts do not affect liver function tests in rats","volume":"69","author":"Singh","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2019.01.032_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.phymed.2006.01.006","article-title":"Safety of ethanolic kava extract: results of a study of chronic toxicity in rats","volume":"13","author":"Sorrentino","year":"2006","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.jep.2019.01.032_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ptr.3283","article-title":"Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro","volume":"25","author":"Tang","year":"2011","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.jep.2019.01.032_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1078\/0944-7113-00314","article-title":"Kava extracts: safety and risks including rare hepatotoxicity","volume":"10","author":"Teschke","year":"2003","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.jep.2019.01.032_bib44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jep.2009.03.038","article-title":"Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures","volume":"123","author":"Teschke","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2019.01.032_bib45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.dld.2011.01.018","article-title":"Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits","volume":"43","author":"Teschke","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jep.2019.01.032_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-979474","article-title":"Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial","volume":"30","author":"Volz","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jep.2019.01.032_bib47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s13197-013-1047-2","article-title":"Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents","volume":"52","author":"Wang","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.jep.2019.01.032_bib48","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1124\/dmd.105.005892","article-title":"Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro","volume":"33","author":"Weiss","year":"2005","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.jep.2019.01.032_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1078\/0944-7113-00068","article-title":"Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots","volume":"9","author":"Wu","year":"2002","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2019.01.032_bib50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11418-007-0203-2","article-title":"Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots","volume":"62","author":"Xuan","year":"2007","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.jep.2019.01.032_bib51","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/j.fct.2008.09.052","article-title":"High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats","volume":"46","author":"Yamazaki","year":"2008","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"10.1016\/j.jep.2019.01.032_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1078\/0944711041495263","article-title":"Effects of kava (Kava-kava, \u2019Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes","volume":"11","author":"Zou","year":"2004","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874118340534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874118340534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T12:34:52Z","timestamp":1720960492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874118340534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":52,"alternative-id":["S0378874118340534"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2019.01.032","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum)","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2019.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Applied Food Sciences, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}